Epithelial to Mesenchymal Transition in Human Mesothelial Cells Exposed to Asbestos Fibers: Role of TGF-β as Mediator of Malignant Mesothelioma Development or Metastasis via EMT Event.
Antibodies
/ immunology
Asbestos, Serpentine
/ toxicity
Cadherins
/ genetics
Cell Line
Down-Regulation
/ drug effects
Epithelial Cells
/ cytology
Epithelial-Mesenchymal Transition
/ drug effects
Fibronectins
/ genetics
Humans
Lung Neoplasms
/ chemically induced
Matrix Metalloproteinase 2
/ genetics
Mesothelioma
/ chemically induced
Mesothelioma, Malignant
Smad Proteins
/ genetics
Snail Family Transcription Factors
/ genetics
Transforming Growth Factor beta
/ immunology
Up-Regulation
/ drug effects
Vimentin
/ genetics
Zinc Finger E-box-Binding Homeobox 1
/ genetics
beta Catenin
/ genetics
TGF-β
asbestos
chrysotile
epithelial-mesenchymal transition
malignant mesothelioma
mesothelium
Journal
International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791
Informations de publication
Date de publication:
03 Jan 2019
03 Jan 2019
Historique:
received:
01
12
2018
revised:
24
12
2018
accepted:
27
12
2018
entrez:
6
1
2019
pubmed:
6
1
2019
medline:
12
4
2019
Statut:
epublish
Résumé
Asbestos exposure increases the risk of asbestosis and malignant mesothelioma (MM). Both fibrosis and cancer have been correlated with the Epithelial to Mesenchymal Transition (EMT)-an event involved in fibrotic development and cancer progression. During EMT, epithelial cells acquire a mesenchymal phenotype by modulating some proteins. Different factors can induce EMT, but Transforming Growth Factor β (TGF-β) plays a crucial role in promoting EMT. In this work, we verified if EMT could be associated with MM development. We explored EMT in human mesothelial cells (MeT-5A) exposed to chrysotile asbestos: we demonstrated that asbestos induces EMT in MeT-5A cells by downregulating epithelial markers E-cadherin, β-catenin, and occludin, and contemporarily, by upregulating mesenchymal markers fibronectin, α-SMA, and vimentin, thus promoting EMT. In these cells, this mechanism is mediated by increased TGF-β secretion, which in turn downregulates E-cadherin and increases fibronectin. These events are reverted in the presence of TGF-β antibody, via a Small Mother Against Decapentaplegic (SMAD)-dependent pathway and its downstream effectors, such as Zinc finger protein SNAI1 (SNAIL-1), Twist-related protein (Twist), and Zinc Finger E-Box Binding Homeobox 1 (ZEB-1), which downregulate the
Identifiants
pubmed: 30609805
pii: ijms20010150
doi: 10.3390/ijms20010150
pmc: PMC6337211
pii:
doi:
Substances chimiques
Antibodies
0
Asbestos, Serpentine
0
Cadherins
0
Fibronectins
0
SNAI1 protein, human
0
Smad Proteins
0
Snail Family Transcription Factors
0
Transforming Growth Factor beta
0
Vimentin
0
ZEB1 protein, human
0
Zinc Finger E-box-Binding Homeobox 1
0
beta Catenin
0
Matrix Metalloproteinase 2
EC 3.4.24.24
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Références
Thorax. 1999 Jul;54(7):638-52
pubmed: 10377212
Biochem Pharmacol. 2000 Oct 15;60(8):1091-9
pubmed: 11007946
Mol Biol Cell. 2001 Jan;12(1):27-36
pubmed: 11160820
Int Immunopharmacol. 2002 Feb;2(2-3):191-200
pubmed: 11811924
J Clin Invest. 2003 Dec;112(12):1776-84
pubmed: 14679171
Mutat Res. 2004 Mar 14;558(1-2):81-92
pubmed: 15036122
Lab Invest. 2004 Aug;84(8):1013-23
pubmed: 15122306
Int J Dev Biol. 2004;48(5-6):365-75
pubmed: 15349812
Nat Cell Biol. 2004 Oct;6(10):931-40
pubmed: 15448698
Cancer Biol Ther. 2006 Sep;5(9):1059-64
pubmed: 16940750
Neurochem Res. 2007 Apr-May;32(4-5):577-95
pubmed: 16944320
Nat Rev Cancer. 2007 Jun;7(6):415-28
pubmed: 17508028
J Immunotoxicol. 2008 Apr;5(2):145-9
pubmed: 18569384
Transl Res. 2009 Apr;153(4):143-52
pubmed: 19304273
J Clin Invest. 2009 Jun;119(6):1420-8
pubmed: 19487818
Eur J Cardiothorac Surg. 2010 Mar;37(3):566-72
pubmed: 19781955
Proc Jpn Acad Ser B Phys Biol Sci. 2009;85(8):314-23
pubmed: 19838011
Antioxid Redox Signal. 2010 Jun 15;12(12):1383-430
pubmed: 19903090
Cancer Lett. 2011 Mar 28;302(2):136-43
pubmed: 21300430
Asian Pac J Trop Med. 2011 Dec;4(12):925-30
pubmed: 22118025
Semin Cancer Biol. 2012 Oct;22(5-6):446-54
pubmed: 22548724
J Cell Biochem. 2012 Jul;113(7):2234-47
pubmed: 22573546
APMIS. 2013 Jan;121(1):1-10
pubmed: 23030626
Am J Pathol. 2013 Nov;183(5):1654-66
pubmed: 24160326
Nat Rev Mol Cell Biol. 2014 Mar;15(3):178-96
pubmed: 24556840
J Cell Physiol. 2014 Nov;229(11):1647-59
pubmed: 24610459
J Proteome Res. 2014 Jun 6;13(6):2874-86
pubmed: 24766643
Cells. 2014 Oct 15;3(4):981-93
pubmed: 25317929
Int J Oncol. 2014 Dec;45(6):2522-32
pubmed: 25358858
Environ Health Perspect. 2016 Jun;124(6):776-84
pubmed: 26685284
BMC Cancer. 2018 Aug 15;18(1):819
pubmed: 30111297
Int J Mol Sci. 2018 Aug 20;19(8):null
pubmed: 30127261
Int J Mol Sci. 2018 Nov 15;19(11):null
pubmed: 30445777
Semin Cancer Biol. 2018 Nov 16;:null
pubmed: 30453041
Nat Rev Mol Cell Biol. 2018 Nov 20;:null
pubmed: 30459476
Int J Mol Sci. 2018 Nov 20;19(11):null
pubmed: 30463358